54,590 Shares in Ingevity Corporation $NGVT Purchased by WINTON GROUP Ltd

WINTON GROUP Ltd acquired a new stake in Ingevity Corporation (NYSE:NGVT) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 54,590 shares of the company’s stock, valued at approximately $2,352,000. WINTON GROUP Ltd owned approximately 0.15% of Ingevity at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the stock. Elevation Point Wealth Partners LLC bought a new stake in shares of Ingevity during the second quarter valued at approximately $60,000. BI Asset Management Fondsmaeglerselskab A S lifted its holdings in Ingevity by 21.6% during the 1st quarter. BI Asset Management Fondsmaeglerselskab A S now owns 1,670 shares of the company’s stock worth $66,000 after buying an additional 297 shares in the last quarter. EverSource Wealth Advisors LLC boosted its position in Ingevity by 51.6% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,616 shares of the company’s stock valued at $70,000 after buying an additional 550 shares during the last quarter. Empowered Funds LLC boosted its position in Ingevity by 12.9% in the 1st quarter. Empowered Funds LLC now owns 5,181 shares of the company’s stock valued at $205,000 after buying an additional 594 shares during the last quarter. Finally, Keybank National Association OH acquired a new stake in shares of Ingevity in the 2nd quarter valued at $206,000. 91.59% of the stock is owned by institutional investors.

Ingevity Price Performance

Ingevity stock opened at $56.17 on Wednesday. The company has a current ratio of 1.27, a quick ratio of 0.80 and a debt-to-equity ratio of 8.39. The firm has a market capitalization of $2.02 billion, a P/E ratio of -30.86 and a beta of 1.40. The business has a 50-day moving average of $52.79 and a 200-day moving average of $50.50. Ingevity Corporation has a 1 year low of $28.49 and a 1 year high of $60.77.

Ingevity (NYSE:NGVT) last issued its quarterly earnings data on Friday, March 24th. The company reported $0.78 earnings per share (EPS) for the quarter. The firm had revenue of $336.00 million during the quarter. Ingevity had a negative net margin of 5.14% and a positive return on equity of 103.69%. On average, equities analysts anticipate that Ingevity Corporation will post 4.45 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. Wall Street Zen downgraded Ingevity from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Weiss Ratings restated a “sell (d-)” rating on shares of Ingevity in a research report on Wednesday, October 8th. Wells Fargo & Company boosted their price target on shares of Ingevity from $52.00 to $55.00 and gave the stock an “equal weight” rating in a research note on Wednesday, November 12th. Finally, BMO Capital Markets increased their price objective on shares of Ingevity from $64.00 to $70.00 and gave the company an “outperform” rating in a report on Wednesday. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Ingevity currently has an average rating of “Hold” and an average price target of $62.50.

About Ingevity

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.